We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
Cap. Flow
+$135M
Cap. Flow %
6.32%
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.04M
2
CVS icon
CVS Health
CVS
+$650K
3
CIVB icon
Civista Bancshares
CIVB
+$555K
4
MMM icon
3M
MMM
+$392K
5
UL icon
Unilever
UL
+$357K

Sector Composition

Rank Sector Weight
1 Technology 7.84%
2 Financials 7.12%
3 Consumer Staples 1.93%
4 Healthcare 1.77%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
201
Alibaba
BABA
$276B
$436K 0.02%
6,055
+946
+19% +$72.5K
FCX icon
202
Freeport-McMoran
FCX
$88.6B
$436K 0.02%
8,965
+1,231
+16% +$62K
ETN icon
203
Eaton
ETN
$150B
$436K 0.02%
1,389
-25
-2% -$8.07K
PHM icon
204
Pultegroup
PHM
$25.7B
$425K 0.02%
3,863
PDI icon
205
PIMCO Dynamic Income Fund
PDI
$7.42B
$425K 0.02%
22,572
ITW icon
206
Illinois Tool Works
ITW
$84.9B
$419K 0.02%
1,768
+3
+0.2% +$741
BF.B icon
207
Brown-Forman Class B
BF.B
$13.3B
$418K 0.02%
9,674
-510
-5% -$24K
WRK
208
DELISTED
WestRock Company
WRK
$416K 0.02%
8,277
EMR icon
209
Emerson Electric
EMR
$85B
$413K 0.02%
3,747
MFC icon
210
Manulife Financial
MFC
$74.2B
$407K 0.02%
15,301
TSM icon
211
TSMC
TSM
$2.03T
$405K 0.02%
2,331
-69
-3% -$10.5K
GIS icon
212
General Mills
GIS
$20.1B
$401K 0.02%
6,346
+2
+0% +$137
BP icon
213
BP
BP
$107B
$401K 0.02%
11,117
+4
+0% +$150
VTEB icon
214
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
$399K 0.02%
7,960
+61
+0.8% +$3.05K
CRM icon
215
Salesforce
CRM
$149B
$397K 0.02%
1,543
-41
-3% -$11K
IVW icon
216
iShares S&P 500 Growth ETF
IVW
$71.9B
$396K 0.02%
4,282
+3
+0.1% +$259
VRTX icon
217
Vertex Pharmaceuticals
VRTX
$124B
$390K 0.02%
832
+100
+14% +$43.4K
SBUX icon
218
Starbucks
SBUX
$118B
$388K 0.02%
4,983
-182
-4% -$14.8K
SHW icon
219
Sherwin-Williams
SHW
$87.4B
$376K 0.02%
1,260
-76
-6% -$23.5K
SOLV icon
220
Solventum
SOLV
$14.9B
$354K 0.02%
+6,698
New +$407K
KIM icon
221
Kimco Realty
KIM
$17.7B
$350K 0.02%
17,981
+1,000
+6% +$18.7K
C icon
222
Citigroup
C
$222B
$345K 0.02%
5,432
+3
+0.1% +$185
SPDW icon
223
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.6B
$344K 0.02%
9,808
+4,017
+69% +$143K
GSBD icon
224
Goldman Sachs BDC
GSBD
$1,000M
$343K 0.02%
22,830
+14
+0.1% +$215
STRM
225
DELISTED
Streamline Health Solutions
STRM
$341K 0.02%
49,399

Similar funds

Nicholas Hoffman & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.

  • Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
  • Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
  • Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
  • Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
  • Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
  • Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
  • Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.